Possibility for the use of bromhexine to prevent infection with SARS-CoV-2

The routine use of bromhexine to prevent infection SARS-CoV-2 is not recommended. The use of bromhexine is possible in clinical trials.

Saved in:

Bibliographic Details
Published in:	Kachestvennai͡a︡ klinicheskai͡a︡ praktika no. 4S; pp. 8 - 10
Main Authors:	Zagorodnikova, K. A., Mirzaev, K. B., Sychev, D. A.
Format:	Journal Article
Language:	English Russian
Published:	Izdatelstvo OKI 28-10-2020
Subjects:	covid-19 бромгексин коронавирус
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	The routine use of bromhexine to prevent infection SARS-CoV-2 is not recommended. The use of bromhexine is possible in clinical trials.
AbstractList	The routine use of bromhexine to prevent infection SARS-CoV-2 is not recommended. The use of bromhexine is possible in clinical trials.
Author	Zagorodnikova, K. A. Mirzaev, K. B. Sychev, D. A.
Author_xml	– sequence: 1 givenname: K. A. orcidid: 0000-0002-5251-5319 surname: Zagorodnikova fullname: Zagorodnikova, K. A. organization: National Medical Research Center named after V.A. Almazov of the Ministry of Health of Russia – sequence: 2 givenname: K. B. orcidid: 0000-0002-9307-4994 surname: Mirzaev fullname: Mirzaev, K. B. organization: Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia – sequence: 3 givenname: D. A. orcidid: 0000-0002-4496-3680 surname: Sychev fullname: Sychev, D. A. organization: Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia
BookMark	eNo9kMlOwzAURS0EEqX0G_APGDzG9rKqGIoqgQiwteLkmRq1ceWEoX9P0wKre3Xf01mcM3TcphYQumD0Umhp7BVXxhCqmCWcckpKSQxh9AiNeMEMMVKL413_ezpFk66LnkqpFRVaj9D9YxqWuIr9FoeUcb8E_NEBTgH7nNZL-I4t4D7hTYZPaHsc2wB1H1OLv2K_xOX0qSSz9Er4OToJ1aqDyW-O0cvN9fPsjiwebuez6YLUrBCUSMsgKNF4w0woTKUFBWuCBGmD0sz6RhdSFIF6URVcF54Kz1XgnoeCNgBijOYHbpOqd7fJcV3lrUtVdPsh5TdX5T7WK3AeGska1dTCUMkUtYIxXdWM2iA8cLlj6QOrzjsPGcI_j1G3N-wGeW6Q5wbDrpTO7I7iBx6Tbzo
Cites_doi	10.1016/j.phrs.2020.104837 10.1016/j.cell.2020.02.052 10.1002/9781118541203.xen126 10.1158/2159-8290.CD-13-1010 10.1101/2020.02.08.926006 10.1080/004982500237839 10.1128/AAC.01043-16 10.26434/chemrxiv.12162360.v1 10.1002/bdd.2510030407
ContentType	Journal Article
DBID	AAYXX CITATION DOA
DOI	10.37489/2588-0519-2020-S4-8-10
DatabaseName	CrossRef DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef
DatabaseTitleList	CrossRef
Database_xml	– sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	2618-8473
EndPage	10
ExternalDocumentID	oai_doaj_org_article_bed41d5dc380415093117ac109f3be24 10_37489_2588_0519_2020_S4_8_10
GroupedDBID	AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION GROUPED_DOAJ
ID	FETCH-LOGICAL-c1630-491ef53db818f68a730e98f4e49f5719bd76436f0b3a6276b03b25f2b2f60dee3
IEDL.DBID	DOA
ISSN	2588-0519
IngestDate	Tue Oct 22 15:15:11 EDT 2024 Thu Nov 21 23:49:29 EST 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4S
Language	English Russian
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c1630-491ef53db818f68a730e98f4e49f5719bd76436f0b3a6276b03b25f2b2f60dee3
ORCID	0000-0002-5251-5319 0000-0002-9307-4994 0000-0002-4496-3680
OpenAccessLink	https://doaj.org/article/bed41d5dc380415093117ac109f3be24
PageCount	3
ParticipantIDs	doaj_primary_oai_doaj_org_article_bed41d5dc380415093117ac109f3be24 crossref_primary_10_37489_2588_0519_2020_S4_8_10
PublicationCentury	2000
PublicationDate	2020-10-28
PublicationDateYYYYMMDD	2020-10-28
PublicationDate_xml	– month: 10 year: 2020 text: 2020-10-28 day: 28
PublicationDecade	2020
PublicationTitle	Kachestvennai͡a︡ klinicheskai͡a︡ praktika
PublicationYear	2020
Publisher	Izdatelstvo OKI
Publisher_xml	– name: Izdatelstvo OKI
References	ref8 ref7 ref9 ref4 ref3 ref6 ref11 ref5 ref10 ref2 ref1
References_xml	– ident: ref5 doi: 10.1016/j.phrs.2020.104837 – ident: ref6 – ident: ref8 doi: 10.1016/j.cell.2020.02.052 – ident: ref2 doi: 10.1002/9781118541203.xen126 – ident: ref3 doi: 10.1158/2159-8290.CD-13-1010 – ident: ref4 doi: 10.1101/2020.02.08.926006 – ident: ref1 doi: 10.1080/004982500237839 – ident: ref7 doi: 10.1128/AAC.01043-16 – ident: ref9 doi: 10.26434/chemrxiv.12162360.v1 – ident: ref11 doi: 10.1002/bdd.2510030407 – ident: ref10
SSID	ssib044750377 ssj0002874179
Score	2.1762612
Snippet	The routine use of bromhexine to prevent infection SARS-CoV-2 is not recommended. The use of bromhexine is possible in clinical trials.
SourceID	doaj crossref
SourceType	Open Website Aggregation Database
StartPage	8
SubjectTerms	covid-19 бромгексин коронавирус
Title	Possibility for the use of bromhexine to prevent infection with SARS-CoV-2
URI	https://doaj.org/article/bed41d5dc380415093117ac109f3be24
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7ag3gRn1hf5OA1NI_dTfZYa0sRFHFVvIXNJkEEu6UP0H_vJLst9eTFaxLC8s2E-SaZ_QahaymdSUvDiITYQhJlPTE0A4NwOB5V6SyNugXjQj68qdthkMlZt_oKNWGNPHADXM84mzCb2kpEpRxIwBmTZcVo7oVxvFECpdlGMgWeFFTsqGj_sPyIV0gytNoKneZScI3AW5pir6i-0lsPgtNAOlUkJGie_gpVG4r-MfSM9tFeyxlxv_nWA7Q1Wx6infv2VfwI3T3W87bK9RsDCcVA6vBy7nDtsZnVn-_uC9bhRY2njWATXpVgTXC4h8VF_6kgg_qV8GP0Mho-D8ak7ZFAKmBSgG7OnE-FNRB4faZKOLAuVz5xSe5TyXJjJXCOzFMjyozLzFBheOq54T6j1jlxgjqTeuJOEWZCGQkbQXptEpNXSnrLhFVVWtHUVHkX0RUcetpIYWhIISKCOiCoA4I6IKiLRCuY7KKbANt6edCyjgNgYd1aWP9l4bP_2OQc7UbTgkNydYE6i9nSXaLtuV1eRc_5ASEDv28
link.rule.ids	315,782,786,866,2106,27933,27934
linkProvider	Directory of Open Access Journals
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Possibility+for+the+use+of+bromhexine+to+prevent+infection+with+SARS-CoV-2&rft.jtitle=Kachestvennai%CD%A1a%EF%B8%A1+klinicheskai%CD%A1a%EF%B8%A1+praktika&rft.au=K.+A.+Zagorodnikova&rft.au=K.+B.+Mirzaev&rft.au=D.+A.+Sychev&rft.date=2020-10-28&rft.pub=Izdatelstvo+OKI&rft.issn=2588-0519&rft.eissn=2618-8473&rft.issue=4S&rft.spage=8&rft.epage=10&rft_id=info:doi/10.37489%2F2588-0519-2020-S4-8-10&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_bed41d5dc380415093117ac109f3be24
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2588-0519&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2588-0519&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2588-0519&client=summon